April 29, 2020

Greg Accetturo, ANT Neuro’s Senior Director of US Sales and Global Marketing, is pleased to announce that ANT Neuro has signed an agreement with International Biomedical to represent ANT Neuro’s nëo™ neonatal aEEG/EEG System in the United States’ Neonatal Intensive Care  Unit (NICU) market.

“Over the last 20 years ANT Neuro’s high-quality, research grade neurology products have been available globally to assist research and clinical professionals in obtaining critical brain function information.” said Frank Zanow, CEO, ANT Neuro. 

Representing one of the top national distributors of products with specific application in the NICU, International Biomedical offers a full line of specialty devices and medical supplies to NICUs throughout the United States. With over 50 sales professionals and 15 clinical and technical support personnel, International Biomedical has one of the largest and most experienced sales and support teams serving the NICU.

“We are excited to have International Biomedical partner with ANT Neuro.They have significant long-term relationships and distribution experience with professional caregivers in the NICU. Together we can continue to expand International Biomedical’s products and services into the NICU care area,” said Zanow.

“International Biomedical is committed to providing our NICU customers with industry-leading options that they can rely on to help improve patient care,” said John Segars, CEO, International Biomedical. “We are pleased to team up with ANT Neuro to bring this cutting-edge neonatal brain monitoring system to NICUs in the United States” said Segars.

For over 50 years, International Biomedical, headquartered in Austin, Texas, has been recognized by the industry as a leading provider of innovative medical devices.

For more information contact:
sales@ant-neuro.com or sales@int-bio.com

FOR IMMEDIATE RELEASE
Greg Accetturo
Senior Director, US Sales and Global Marketing
ANT Neuro